Objective: To analyse changes in muscle strength, physical performance and quality of life during intravenous immunoglobulin (IVIg) treatment in patients with post-polio syndrome. Design: Open clinical trial. Patients: A total of 14 patients (6 women, 8 men; mean age 57 years, range 43–67 years) were included in the study. Intervention: Treatment with 90 g IVIg (30 g daily for 3 days). Main outc ...
Pages: 138-140